Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

SABEY

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 1
Rounds per year 0.02
Lead investments 0
Key employees Soon

Areas of investment

  • Health Care
  • Health Diagnostics
  • Biotechnology
Summary

SABEY appeared to be the Corporate Investor, which was created in 1971. The main office of represented Corporate Investor is situated in the Seattle. The venture was found in North America in United States.

The important activity for fund was in 2017. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Health Care. Among the most popular portfolio startups of the fund, we may highlight Indi Molecular. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

The typical case for the fund is to invest in rounds with 4 participants. Despite the SABEY, startups are often financed by InterWest Partners, Asset Management Ventures (AMV). The meaningful sponsors for the fund in investment in the same round are M Ventures, Legend Capital, Asset Management Ventures (AMV).

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of SABEY:
Typical Co-investors
SABEY is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after SABEY:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Acappella Partners -
Allston Venture Fund Allston, Massachusetts, United States
Alto Partners Multi-Family Office Central Region, Singapore, Singapore
Danske Bank Copenhagen, Denmark, Hovedstaden
Elige Capital France, Ile-de-France, Paris
Gen-Probe California, San Diego, United States
Guoyuan Capital Anhui, China, Hefei
Impact Collective -
ISME ACE - FinTech Accelerator India, Maharashtra, Mumbai
Macate Group California, San Jose, United States
Nanji Quan China, Guangdong, Shenzhen
Paramount Capital Memphis, Tennessee, United States
PCRS Capital Partners California, Long Beach, United States
Polyvalor Inc -
R.W. Pressprich & Co New York, New York, United States
Shengshi Jinhao Investment Management -
Shenzhen O-film Technology China, Guangming, Hunan
Shenzhenshi Baohualun Shiye Youxian Gongsi China, Guangdong, Shenzhen
Yiju Zichan China, Shanghai
Zhongdian Health Industry Fund Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Indi Molecular

Biotechnology
Health Care
Health Diagnostics
$11M29 Jun 2017 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent SABEY?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 11M
Rounds per year 0.02
Peak activity year 2017
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Indi Molecular

Biotechnology
Health Care
Health Diagnostics
$11M29 Jun 2017 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: